Çankaya GCRIS Standart veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Wavelet analysis for the multicomponent determination in a binary mixture of caffeine and propyphenazone in tablets

No Thumbnail Available

Date

2004

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier Masson SAS

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Organizational Unit
Matematik
Bölümümüz, bilim ve sanayi için gerekli modern bilgilere sahip iş gücünü üretmeyi hedeflemektedir.

Journal Issue

Events

Abstract

An approach based on both discrete and continuous wavelet analysis followed by a zero-crossing technique was developed. We applied this approach to obtain a high resolution in the binary mixture of caffeine (CA) and propyphenazone (PR) in the presence of their overlapping signals in the working length. The optimization of the wavelet families was accomplished for this mixture. The de-noise procedure was carried out by using 4-level Haar discrete wavelet transform and the resulted de-noised signal was investigated by continuous Mexican (MEX) and Haar (HA) transforms. Finally, a zero-crossing technique was applied on the transformed signal and the constructed calibration was tested by analyzing the composition of the different mixture containing CA and PR. All calculations have been performed within EXCEL and Matlab 6.5 software. The obtained results indicate that our procedure is flexible and applicable for the mixture analysis. © 2004 Elsevier SAS. All rights reserved.

Description

Keywords

Binary Mixture, Caffeine, De-Noising, High-Resolution, Propyphenazone, Wavelet Families

Turkish CoHE Thesis Center URL

Fields of Science

Citation

Dinç, Erdal...et al. (2004). "Wavelet analysis for the multicomponent determination in a binary mixture of caffeine and propyphenazone in tablets", Farmaco, Vol. 59, No. 4, pp. 335-342.

WoS Q

N/A

Scopus Q

N/A

Source

Farmaco

Volume

59

Issue

4

Start Page

335

End Page

342